| Bioactivity | Isomitomycin A is a potential inhibitor against SARS-CoV-2. Isomitomycin A targets to the hACE2 binding site of the modelled surface glycoprotein of SARS-CoV-2. Isomitomycin A can be used in studies of COVID-19[1]. |
| Name | Isomitomycin A |
| CAS | 91917-64-5 |
| Formula | C16H19N3O6 |
| Molar Mass | 349.34 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Basak H K, et al. Sequence Analysis, Structure Prediction of Receptor Proteins and In Silico Study of Potential Inhibitors for Management of Life Threatening COVID-19[J]. Letters in Drug Design & Discovery, 2022, 19(2): 108-122. |
Isomitomycin A
CAS: 91917-64-5 F: C16H19N3O6 W: 349.34
Isomitomycin A is a potential inhibitor against SARS-CoV-2. Isomitomycin A targets to the hACE2 binding site of the mode
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.